DK105027C - Fremgangsmåde til fremstilling af derivater af Cephalosporin C, Cephalosporin Cc eller af Cephalosporin CA-forbindelser. - Google Patents

Fremgangsmåde til fremstilling af derivater af Cephalosporin C, Cephalosporin Cc eller af Cephalosporin CA-forbindelser.

Info

Publication number
DK105027C
DK105027C DK307160AA DK307160A DK105027C DK 105027 C DK105027 C DK 105027C DK 307160A A DK307160A A DK 307160AA DK 307160 A DK307160 A DK 307160A DK 105027 C DK105027 C DK 105027C
Authority
DK
Denmark
Prior art keywords
cephalosporin
derivatives
compounds
preparation
Prior art date
Application number
DK307160AA
Other languages
English (en)
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB26569/59A external-priority patent/GB953695A/en
Priority claimed from GB213560A external-priority patent/GB966221A/en
Application filed by Nat Res Dev filed Critical Nat Res Dev
Application granted granted Critical
Publication of DK105027C publication Critical patent/DK105027C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D501/06—Acylation of 7-aminocephalosporanic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Structure Of Belt Conveyors (AREA)
  • Cephalosporin Compounds (AREA)
DK307160AA 1959-08-04 1960-08-03 Fremgangsmåde til fremstilling af derivater af Cephalosporin C, Cephalosporin Cc eller af Cephalosporin CA-forbindelser. DK105027C (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB26569/59A GB953695A (en) 1959-08-04 1959-08-04 Derivatives of cephalosporin c
GB213560A GB966221A (en) 1960-01-20 1960-01-20 N-acyl derivatives of 7-aminocephalosporanic acid and related compounds
GB2368360 1960-07-06

Publications (1)

Publication Number Publication Date
DK105027C true DK105027C (da) 1966-08-08

Family

ID=27254024

Family Applications (1)

Application Number Title Priority Date Filing Date
DK307160AA DK105027C (da) 1959-08-04 1960-08-03 Fremgangsmåde til fremstilling af derivater af Cephalosporin C, Cephalosporin Cc eller af Cephalosporin CA-forbindelser.

Country Status (6)

Country Link
CH (1) CH404860A (da)
DK (1) DK105027C (da)
NL (1) NL6608907A (da)
NO (1) NO122748B (da)
OA (1) OA01264A (da)
SE (1) SE309986B (da)

Also Published As

Publication number Publication date
SE309986B (da) 1969-04-14
OA01264A (fr) 1969-02-15
CH404860A (fr) 1965-12-31
NO122748B (da) 1971-08-09
NL6608907A (da) 1966-08-25

Similar Documents

Publication Publication Date Title
DK126687B (da) Analogifremgangsmåde til fremstilling af glucofuranosider eller 2-0-acylderivater deraf.
DK109144C (da) Fremgangsmåde til fremstilling af s-triazinderivater.
DK119710B (da) Fremgangsmåde til fremstilling af polyozoaluminiumforbindelser.
DK105027C (da) Fremgangsmåde til fremstilling af derivater af Cephalosporin C, Cephalosporin Cc eller af Cephalosporin CA-forbindelser.
DK94623C (da) Fremgangsmåde til fremstilling af 7-teofyllinderivater.
DK107164C (da) Fremgangsmåde til fremstilling af 18-acyloxy- eller 18-hydroxy-pregnan-forbindelser.
DK104677C (da) Fremgangsmåde til fremstilling af 3-halogen-iminodibenzylforbindelser.
DK96791C (da) Fremgangsmåde til fremstilling af nitrofuranderivater.
DK102677C (da) Fremgangsmåde til fremstilling af phenylethyl-octalin- eller -tetrahydroindanforbindelser.
DK92023C (da) Fremgangsmåde til fremstilling af β-aminoalkylthianaphthen- eller β-aminoalkylbenzofuran-forbindelser.
DK101916C (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-5-methoxy- eller ethoxy-pyrimidinforbindelser.
DK95414C (da) Fremgangsmåde til fremstilling af 9α-fluor-11β-hydroxy- eller 11-oxo-16α-methylprogesteron-forbindelser.
DK94409C (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-5-methoxy- eller ethoxypyrimidinforbindelser.
DK97030C (da) Fremgangsmåde til fremstilling af neopentylferrocenderivater.
DK96511C (da) Fremgangsmåde til fremstilling af N-desulfoheparylurinstofderivater.
DK94461C (da) Fremgangsmåde til fremstilling af monopivaloylferrocenderivater.
DK96460C (da) Fremgangsmåde til fremstilling af tiadiazolforbindelser.
DK94782C (da) Fremgangsmåde til fremstilling af 2-oxo-benzoquinolizinforbindelser eller salte deraf.
DK101300C (da) Fremgangsmåde til fremstilling af 3-amino-4-phenylpyrazolforbindelser eller salte deraf.
DK94222C (da) Fremgangsmåde til fremstilling af dihydrazinotriazinforbindelser eller salte deraf.
DK95529C (da) Fremgangsmåde til fremstilling af 5-aryl-5-alkyl-hexahydropyrimidin-4,6-dionderivater.
DK95415C (da) Fremgangsmåde til fremstilling af ferrocenderivater.
DK95637C (da) Fremgangsmåde til fremstilling af ferrocenderivater.
DK95586C (da) Fremgangsmåde til fremstilling af ferrocenderivater.
DK101857C (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-5-alkoksypyrimidinforbindelser.